EWSR1 and Ewing sarcoma: Recapitulating this observation, we demonstrated SP2509 treatment acts similarly to EWSR1-FLI1 knockdown by shifting multiple Ewing sarcoma cell lines significantly higher on PHATE_1 (Figure S6B,C).